Ellis J, Lenox R H
Biochem Biophys Res Commun. 1985 Feb 15;126(3):1242-50. doi: 10.1016/0006-291x(85)90319-5.
Atropine and scopolamine inhibit the binding of [3H] quinuclidinyl benzilate (QNB) to muscarinic receptors of rat forebrain in a manner that suggests homogeneity of the binding sites. Under the same conditions, the inhibition by N-methylatropine (NMA) and N-methylscopolamine (NMS) of the binding of [3H]QNB is consistent with the presence of subpopulations of receptors that differ greatly in affinities toward these quaternary ligands. The subpopulations that are defined according to the affinities of NMA and NMS correlate very well with those that are defined by the use of gallamine. It is suggested that the heterogeneity in the binding of NMS explains some of the anomalous interactions between NMS and gallamine that have been reported previously.
阿托品和东莨菪碱抑制[3H]奎宁环基苯甲酸酯(QNB)与大鼠前脑毒蕈碱受体的结合,这种方式表明结合位点具有同质性。在相同条件下,N - 甲基阿托品(NMA)和N - 甲基东莨菪碱(NMS)对[3H]QNB结合的抑制作用与存在对这些季铵配体亲和力差异很大的受体亚群一致。根据NMA和NMS的亲和力定义的亚群与使用加拉明定义的亚群相关性非常好。有人提出,NMS结合的异质性解释了先前报道的NMS与加拉明之间一些异常相互作用。